Accuracy

Lab me follow a rigorous validation process to assure each biomarker is capable of meeting all precision and reproducibility before inclusion on our test menu.

We use a patented plasma membrane seperation system which out performs traditional dry blood spot cards.

Our approach includes the use of outside research laboratories for specimen collection to incorporate the variability of collected samples into our correlation and stability studies.

College of American Pathologists (CAP’s) Laboratory Accreditation

We use CAP-accredited labs, and our partner labs maintain federal certification, state licenses (permits), and CAP accreditation. Our partner labs demonstrate laboratory proficiency through external and internal quality assessment.

We couple all of that with leading research to deliver your results in an easy to understand format that is accessible from your computer or mobile phone.

finger prick blood test accuracy

Download Our Research Data On Accuracy

Our Labs Are FDA approved

Our most common tests are here but if you would like information for one not listed, let us know and we will send it.

Scientific Excellence

It takes specialized knowledge and years of experience to develop and maintain micro sample analysis.  Unlike other labs, our partnered medical scientists have over twenty-years combined experience in small volume collection techniques and specimen analysis.​

Integrated Data Workflows

Lab Me’s partner lab integration options provide flexibility and range from easy-to-use, Web-based applications to sophisticated integrated workflows.

Specimen Processing

All customer specimens are processed at Lab Me’s partner laboratories single site, centrally located in the heart of the Midwest. Samples arrive daily from all areas of the country. This centralization allows for industry-leading turn-around times on result delivery, consistency in testing quality across all consumer specimens, proactive and immediate oversight of all laboratory activities and personnel.

Paperless Sample Processing

In the age of technology and security Lab Me integrates with partners using minimal information necessary to process participant specimens. Electronic sharing of basic identifying, criteria allows samples to be submitted for immediate processing, avoiding data entry errors, and improving the overall integrity of any returned data.

Turnaround Time

Results of a routine nature are reported within 48 hours from receipt at our partner lab. Turnaround times are based on standard operating schedules and conditions and could change, dependent upon requests. Some tests may, occasionally, require more time to complete due to unforeseen events or circumstances. We work closely with our consumers to ensure client success for long term relationships.

Result Delivery

Lab Me offers many customizable result delivery options. We provide our users with a personalized dashboard that they can access online via mobile or desktop.  This allows for centralization and faster accessing of historical data. In return, our consumer’s healthcare providers benefit by being able to quickly view trends in Lab Me users dashboards.

MD-Reporting
Creatinine measurement on dry blood spot sample for chronic kidney disease screening.

Kidney Disease Screening

Measurement of creatinine on dry blood sample is an easily feasible non-invasive diagnostic test with good accuracy that may be useful to screen chronic kidney disease.

MD-Reporting
Quantification of multiple elements in dried blood spot samples.

Trace Elements Research

Trace elements can be measured with high accuracy and low imprecision in DBS, but contribution of signal from the filter paper influences measurement of some elements present at low concentrations. Simultaneous measurement of K and Fe in DBS extracts may be used to estimate sample hematocrit.

MD-Reporting
Assessment of disease-specific immune responses in enteric diseases using dried blood spot (DBS)

Disease Specific Immune Response

Given that we observed a very positive correlation of immune responses in DBS compared to plasma specimen, we extended this observation to typhoid fever patients. The immune responses against membrane preparation (MP) in DBS eluates were also similar to that seen in plasma samples.

MD-Reporting
Using the same collection device as Lab Me. Trial still in progress.

Mayo Clinic Clinical Trials

The purpose of this study is to evaluate the feasibility of successfully obtaining serial finger-prick blood samples from castrate resistant prostate cancer and metastatic renal cell cancer patients using a specific (HemaSpot-SE ™) collection kit.